The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Cardiovascular Complications Associated With Primary Aldosteronism: A Controlled Cross-Sectional Study
Abstract
A higher risk of cardiovascular events has been reported in patients with primary aldosteronism (PA) than in otherwise similar patients with essential hypertension (EH). However, the evidence is limited by small sample size and potential confounding factors. We, therefore, compared the prevalence of cardiovascular events in 459 patients with PA diagnosed in our hypertension unit from 2001 to 2006 and 1290 controls with EH. PA cases and EH controls were individually matched for sex, age (±2 years), and office systolic blood pressure (±10 mm Hg). Patients with PA and EH differed significantly in duration of hypertension, serum potassium, plasma aldosterone and plasma renin concentrations, aldosterone-to-renin ratio, and urinary aldosterone concentration (P<0.001 for all comparisons). The prevalence of electrocardiographic and echocardiographic left ventricular hypertrophy was about twice higher in patients with PA even after adjustment for hypertension duration. PA patients also had a significantly higher prevalence of coronary artery disease (adjusted odds ratio, 1.9), nonfatal myocardial infarction (adjusted odds ratio, 2.6), heart failure (adjusted odds ratio, 2.9), and atrial fibrillation (adjusted odds ratio, 5.0). The risks associated with PA were similar across levels of serum potassium and plasma aldosterone. To conclude, patients with PA are more likely to have had a cardiovascular complication at diagnosis than otherwise similar patients with EH. Target organ damage and complications disproportionate to blood pressure should be considered as an additional argument for suspecting PA in a given individual and possibly for broadening the scope of screening at the population level.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Primary aldosteronism is also associated with left ventricular hypertrophy, diastolic dysfunction and heart failure, large artery stiffness, oxidative stress, widespread tissue inflammation and fibrosis, and increased resistance vessel remodeling compared with primary hypertension.291–293”
From Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association (2018) · cites this paper as [291]
Citations
Cites
Lang, R. M., Bierig, M., Devereux, R. B., Flachskampf, F. A., Foster, E., Pellikka, P. A., Picard, M. H., Roman, M. J., Seward, J., Shanewise, J. S., et al. (2005) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2005.10.005 · Cited by 11,318
Heart Disease and Stroke Statistics—2012 Update: A Report From the American Heart Association
Writing Group Members, Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., et al. (2012) · Circulation · doi:10.1161/cir.0b013e31823ac046 · Cited by 7,333
Universal Definition of Myocardial Infarction
Thygesen, K. A., Alpert, J. S., White, H. D., TASK FORCE MEMBERS: Chairpersons: Kristian Thygesen (Denmark), J. S. A. (., Biomarker Group: Allan S. Jaffe, C. (., ECG Group: Bernard Chaitman, C.-O. (., Imaging Group: Richard Underwood, C. (., Intervention Group: Jean-Pierre Bassand, C.-O. (., Mendis, S., Implementation Group: Lars C. Wallentin Coordinator (Sweden), F. F.-A. (., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.187397 · Cited by 4,422
Thygesen, K. A. (2007) · Circulation · Cited by 3,126
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.177292 · Cited by 2,805
Sokolow, M., & Lyon, T. P. (1949) · American Heart Journal · doi:10.1016/0002-8703(49)90562-1 · Cited by 1,990
(2000) · Journal of the American Society of Nephrology · Cited by 1,718
Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism
Milliez, P., Girerd, X. J., Plouin, P., Blacher, J., Safar, M. E., & Mourad, J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.015 · Cited by 1,541
Self-citationSIMONE, G. D., Devereux, R. B., Daniels, S. R., Koren, M. J., Meyer, R. A., & Laragh, J. H. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)00540-7 · Cited by 900
Oxford textbook of clinical nephrology
Cameron, S. M. (2013) · Oxford University Press eBooks · Cited by 717
Cited by
Sorted by citations
Items 101–200 of 503
Teruyama, K., Naruse, M., Tsuiki, M., & Kobayashi, H. H. (2021) · Journal of Human Hypertension · doi:10.1038/s41371-020-00465-5 · Cited by 44
Gorenek, B., Boriani, G., Dan, G.-A., Fauchier, L., Fenelon, G., Huang, H., Kudaiberdieva, G., Lip, G. Y. H., Mahajan, R., Potpara, T., et al. (2018) · EP Europace · doi:10.1093/europace/euy051 · Cited by 43
Yang, M.-H., Tyan, Y., Huang, Y.-H., Wang, S., & Chen, S. (2016) · La radiologia medica · doi:10.1007/s11547-016-0662-1 · Cited by 44
Genetic and Genomic Mechanisms of Primary Aldosteronism
Fernandes-Rosa, F. L., Boulkroun, S., & Zennaro, M. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.05.005 · Cited by 43
Fernández-Argüeso, M., Corrales, E. P., Rojano, N. B., Cano, A. M. G., Mendiguchía, L. J., & Castro, M. A. (2021) · Endocrine · doi:10.1007/s12020-021-02704-2 · Cited by 43
PTH: Potential role in management of heart failure
Gruson, D., Buglioni, A., & Burnett, J. C. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.03.029 · Cited by 44
Rossi, E., Perazzoli, F., Negro, A., & Magnani, A. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001384 · Cited by 42
MANAGEMENT OF ENDOCRINE DISEASE: The role of surgical adrenalectomy in primary aldosteronism
Hundemer, G. L., & Vaidya, A. (2020) · European Journal of Endocrinology · doi:10.1530/eje-20-0863 · Cited by 42
Prevalence, diagnosis and outcomes of treatment for primary aldosteronism
Yang, Y., Reincke, M., & Williams, T. A. (2019) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2019.101365 · Cited by 42
Pharmacological treatment of aldosterone excess
Deinum, J., Riksen, N. P., & Lenders, J. W. M. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.07.006 · Cited by 41
Matsumoto, T., Oki, K., Kajikawa, M., Nakashima, A., Maruhashi, T., Iwamoto, Y., Iwamoto, A., Oda, N., Hidaka, T., Kihara, Y., et al. (2015) · Hypertension · doi:10.1161/hypertensionaha.114.05001 · Cited by 41
Old and New Concepts in the Molecular Pathogenesis of Primary Aldosteronism
Prada, E. T. A., Burrello, J., Reincke, M., & Williams, T. A. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.10111 · Cited by 39
Primary aldosteronism: key characteristics at diagnosis: a trend toward milder forms
Heinrich, D. A., Adolf, C., Rump, L. C., Quack, I., Quinkler, M. O., Hahner, S., Januszewicz, A., Seufert, J., Willenberg, H. S., Nirschl, N., et al. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-0978 · Cited by 39
Is it time to screen all patients with hypertension for primary aldosteronism?
Yang, J., Fuller, P. J., & Stowasser, M. (2018) · The Medical Journal of Australia · doi:10.5694/mja17.00783 · Cited by 39
Role of estrogen receptors in modulating aldosterone biosynthesis and blood pressure
Rossi, G. P., Caroccia, B., & Seccia, T. M. (2019) · Steroids · doi:10.1016/j.steroids.2019.108486 · Cited by 39
Hacini, I., Sousa, K. D., Boulkroun, S., Méatchi, T., Amar, L., Zennaro, M., & Fernandes-Rosa, F. L. (2021) · European Journal of Endocrinology · doi:10.1530/eje-21-0338 · Cited by 37
Self-citationJuutilainen, A., Savolainen, K., Romppanen, J., Turpeinen, U., Hämäläinen, E. K., Kemppainen, J., Moilanen, L., & Pulkki, K. J. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.03.015 · Cited by 37
Ohno, Y., Sone, M., Inagaki, N., Kawashima, A., Takeda, Y., Yoneda, T., Kurihara, I., Itoh, H., Tsuiki, M., Ichijo, T., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.119.14601 · Cited by 36
Turchi, F., Ronconi, V., di Tizio, V., Ceccoli, L., Boscaro, M., & Giacchetti, G. (2013) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2013.09.009 · Cited by 36
Cardiac Phenotypes in Secondary Hypertension: JACC State-of-the-Art Review.
Januszewicz, A., Mulatero, P., Dobrowolski, P., Monticone, S., van der Niepen, P., Sarafidis, P., Reincke, M., Rexhaj, E., Eisenhofer, G., Januszewicz, M., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.08.714 · Cited by 29
Treatment of Primary Aldosteronism and Organ Protection
Catena, C., Colussi, G., & Sechi, L. A. (2015) · International Journal of Endocrinology · doi:10.1155/2015/597247 · Cited by 34
Liu, P., Zhang, S., Gao, J., Lin, Y., Shi, G., He, W., Touyz, R. M., Yan, L., & Huang, H. (2018) · Hypertension · doi:10.1161/hypertensionaha.117.10644 · Cited by 34
Classification of microadenomas in patients with primary aldosteronism by steroid profiling
Yang, Y., Burrello, J., Burrello, A., Eisenhofer, G., Peitzsch, M., Tetti, M., Knösel, T., Beuschlein, F., Lenders, J. W. M., Mulatero, P., et al. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.01.008 · Cited by 34
Cohen, J. B., Bancos, I., Brown, J. M., Sarathy, H., Turcu, A. F., & Cohen, D. L. (2022) · Annual Review of Medicine · doi:10.1146/annurev-med-042921-100438 · Cited by 36
Barrett, P. Q., Guagliardo, N. A., Klein, P., Hu, C., Breault, D. T., & Beenhakker, M. P. (2016) · The Journal of Physiology · doi:10.1113/jp271896 · Cited by 34
Gómez-Sánchez, C. E., & Oki, K. (2013) · Endocrinology · doi:10.1210/en.2013-1733 · Cited by 33
Kaneko, H., Umakoshi, H., Ogata, M., Wada, N., Iwahashi, N., Fukumoto, T., Yokomoto‐Umakoshi, M., Nakano, Y., Matsuda, Y., Miyazawa, T., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-88712-8 · Cited by 34
Prejbisz, A., Florczak, E., Klisiewicz, A., Dobrowolski, P., Janaszek-Sitkowska, H., Bieleń, P., Szwench-Pietrasz, E., Warchoł-Celińska, E., Kołodziejczyk-Kruk, S., Janas, J., et al. (2013) · Endokrynologia Polska · doi:10.5603/ep.2013.0019 · Cited by 33
Primary Aldosteronism and Cerebrovascular Diseases
Chen, Z.-W., Hung, C., Wu, V.-C., & Lin, Y.-H. (2018) · Endocrinology and Metabolism · doi:10.3803/enm.2018.33.4.429 · Cited by 25
Ozeki, Y., Tanimura, Y., Nagai, S., Nomura, T., Kinoshita, M., Shibuta, K., Matsuda, N., Miyamoto, S., Yoshida, Y., Okamoto, M., et al. (2021) · Diagnostics · doi:10.3390/diagnostics11030433 · Cited by 32
Ibarrola, J., García-Peña, A., Matilla, L., Bonnard, B., Sádaba, R., Arrieta, V., Álvarez, V., Fernández‐Celis, A., Gainza, A., Navarro, A., et al. (2020) · Circulation Research · doi:10.1161/circresaha.119.316427 · Cited by 31
International multicenter survey on screening and confirmatory testing in primary aldosteronism
Naruse, M., Murakami, M., Katabami, T., Kocjan, T., Parasiliti‐Caprino, M., Quinkler, M. O., St‐Jean, M., O’Toole, S. M., Ceccato, F., Kraljević, I., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvac002 · Cited by 31
Local Control of Aldosterone Production and Primary Aldosteronism
Lalli, E., Barhanin, J., Zennaro, M., & Warth, R. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.01.003 · Cited by 30
Lee, S. H., Kim, J. W., Yoon, H., Koh, J.-M., Shin, C. S., Kim, J. H., & Kim, J. H. (2021) · Endocrinology and Metabolism · doi:10.3803/enm.2020.901 · Cited by 30
Kim, K. J., Hong, N., Yu, M. H., Lee, H., Lee, S., Lim, J. S., & Rhee, Y. (2021) · Hypertension · doi:10.1161/hypertensionaha.120.16909 · Cited by 30
Post-saline infusion test aldosterone levels indicate severity and outcome in primary aldosteronism
Weigel, M., Riester, A., Hanslik, G., Lang, K., Willenberg, H. S., Endres, S., Allolio, B., Beuschlein, F., Reincke, M., & Quinkler, M. O. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-1013 · Cited by 30
Hung, C., Chou, C., Wu, X., Chang, Y., Wu, V., Chen, Y., Chang, Y.-S., Tsai, Y., Su, M., Ho, Y., et al. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000619 · Cited by 30
Yang, T., Zhang, H., Liang, Q., Shi, Y., Mei, Y., Barrett, P. Q., & Hu, C. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07094 · Cited by 30
Aldosterone to Renin Ratio as Screening Tool in Primary Aldosteronism
Schilbach, K., Junnila, R. K., & Bidlingmaier, M. (2018) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0672-0836 · Cited by 30
Vorselaars, W. M. C. M., van Beek, D., Postma, E. L., Spiering, W., Rinkes, I. H. M. B., Valk, G. D., Vriens, M. R., Zarnegar, R., Drake, F. T., Duh, Q. Y., et al. (2019) · Surgery · doi:10.1016/j.surg.2019.01.031 · Cited by 29
Therapeutic Outcomes with Surgical and Medical Management of Primary Aldosteronism
Wachtel, H., & Fraker, D. L. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01516-0 · Cited by 29
Zhou, Y., Liu, Q., Wang, X., Wan, J., Liu, S., Luo, T., He, P., Hou, J., Jing, P., Wang, D., et al. (2022) · American Journal of Hypertension · doi:10.1093/ajh/hpac105 · Cited by 28
Morimoto, R., Satani, N., Iwakura, Y., Ono, Y., Kudo, M., Nezu, M., Omata, K., Tezuka, Y., Seiji, K., Ota, H., et al. (2015) · Journal of Human Hypertension · doi:10.1038/jhh.2015.100 · Cited by 28
Primary Aldosteronism: Cardiovascular Outcomes Pre- and Post-treatment
Hundemer, G. L. (2019) · Current Cardiology Reports · doi:10.1007/s11886-019-1185-x · Cited by 27
Heinrich, D. A., Quinkler, M. O., Adolf, C., Handgriff, L., Müller, L., Schneider, H., Sturm, L., Kunzel, H. E., Seidensticker, M., Deniz, S., et al. (2022) · European Journal of Endocrinology · doi:10.1530/eje-21-0541 · Cited by 28
Tagawa, M., Ghosn, M., Wachtel, H., Fraker, D. L., Townsend, R. R., Trerotola, S. O., & Cohen, D. L. (2017) · Journal of Human Hypertension · doi:10.1038/jhh.2016.92 · Cited by 27
Update in diagnosis and management of primary aldosteronism
Dick, S. M., Queiroz, M., Bernardi, B. L., Dall’Agnol, A., Brondani, L. D. A., & Silveiro, S. P. (2017) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2017-0217 · Cited by 28
Huang, W., Chen, Y., Lin, Y., & Chueh, S. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.644260 · Cited by 26
Tsai, C., Chen, Y., Pan, C., Lin, Y.-T., Lee, P.-C., Chiu, Y., Liao, C., Chen, Z., Chang, C., Chang, Y., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.646933 · Cited by 26
Aldosterone and the Mineralocorticoid Receptor: Risk Factors for Cardiometabolic Disorders
Garg, R., & Adler, G. K. (2015) · Current Hypertension Reports · doi:10.1007/s11906-015-0567-8 · Cited by 26
Volpe, C., Hamberger, B., Zedenius, J., & Juhlin, C. C. (2019) · Scandinavian Journal of Surgery · doi:10.1177/1457496918822622 · Cited by 25
Violari, E. G., Arici, M., Singh, C., Caetano, C. M., Georgiades, C. S., Grady, J. J., Tendler, B. R., Shichman, S. J., & Malchoff, C. D. (2019) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.66 · Cited by 25
How common is primary aldosteronism?
Hundemer, G. L., Kline, G. A., & Leung, A. A. C. (2021) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000702 · Cited by 25
Aldosterone-Regulating Receptors and Aldosterone-Driver Somatic Mutations
Lim, J. S., Plaska, S. W., Rege, J., Rainey, W. E., & Turcu, A. F. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.644382 · Cited by 25
Aldosterone suppresses cardiac mitochondria
Hung, C., Chang, Y., Tsai, C., Liao, C., Peng, S., Lee, B., Pan, C., Wu, X.-M., Chen, Z., Wu, V., et al. (2021) · Translational research · doi:10.1016/j.trsl.2021.08.003 · Cited by 25
Functional histopathological markers of aldosterone producing adenoma and somatic KCNJ5 mutations
Fernandes-Rosa, F. L., Amar, L., Tissier, F., Bertherat, J. Y., Méatchi, T., Zennaro, M., & Boulkroun, S. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.01.020 · Cited by 25
Self-citationColussi, G., Novello, M., Uzzau, A., Catena, C., & Sechi, L. A. (2015) · Hormone and Metabolic Research · doi:10.1055/s-0035-1565128 · Cited by 25
Role and Regulation of MicroRNAs in Aldosterone-Mediated Cardiac Injury and Dysfunction in Male Rats
Ball, J. P., Syed, M., Maranon, R. O., Hall, M. E., Roshan, K. C., Reckelhoff, J. F., Cardozo, L. L. Y., & Romero, D. G. (2017) · Endocrinology · doi:10.1210/en.2016-1707 · Cited by 25
Huang, M., Li, J., Zhao, X., Fu, R., Li, X., & Jiang, W. (2024) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2024.102791 · Cited by 26
Molecular and Cellular Mechanisms of Aldosterone Producing Adenoma Development
Boulkroun, S., Fernandes-Rosa, F. L., & Zennaro, M. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00095 · Cited by 24
Role of adrenal vein sampling in primary aldosteronism: Impact of imaging, localization, and age
Wachtel, H., Zaheer, S., Shah, P., Trerotola, S. O., Karakousis, G. C., Roses, R. E., Cohen, D. L., & Fraker, D. L. (2016) · Journal of Surgical Oncology · doi:10.1002/jso.24182 · Cited by 24
Man, J. J., Lu, Q. R., Moss, M. E., Carvajal, B. V., Baur, W. E., Garza, A., Freeman, R. L., Anastasiou, M., Ngwenyama, N., Adler, G. K., et al. (2021) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.121.316929 · Cited by 24
Baguet, J.-P., Steichen, O., Mounier‐Véhier, C., & Gosse, P. (2016) · Annales d Endocrinologie · doi:10.1016/j.ando.2016.01.006 · Cited by 24
Self-citationPan, C., Liao, C., Tsai, C., Chen, Z., Chen, L., Hung, C., Liu, Y., Lin, P., Chang, C., Chang, Y., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.013699 · Cited by 24
Primary aldosteronism in patients with adrenal incidentaloma: is screening appropriate for everyone?
Stavropoulos, K., Imprialos, K. P., Katsiki, N., Petidis, K., Kamparoudis, A., Petras, P., Georgopoulou, V., Finitsis, S., Papadopoulos, C., Athyros, V. G., et al. (2018) · The Journal of Clinical Hypertension · doi:10.1111/jch.13291 · Cited by 23
Taylor, M. J., Ullenbruch, M. R., Frucci, E. C., Rege, J., Ansorge, M. S., Gómez-Sánchez, C. E., Begum, S., Laufer, E., Breault, D. T., & Rainey, W. E. (2019) · Journal of Clinical Investigation · doi:10.1172/jci127429 · Cited by 27
High Prevalence of Autonomous Aldosterone Production in Hypertension: How to Identify and Treat It
Wannachalee, T., Lieberman, L., & Turcu, A. F. (2022) · Current Hypertension Reports · doi:10.1007/s11906-022-01176-7 · Cited by 23
Ueda, T., Tsurutani, Y., Osada, J., Inoue, K., Hoshino, Y., Ono, M., Nakai, K., Saito, J., Yumoto, K., & Nishikawa, T. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.023813 · Cited by 23
Chen, Z., Pan, C., Liao, C., Tsai, C., Chang, Y., Chang, C., Lee, B., Chiu, Y., Huang, W., Wang, S., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac649 · Cited by 23
Of channels and pumps: different ways to boost the aldosterone?
Bandulik, S. (2016) · Acta Physiologica · doi:10.1111/apha.12832 · Cited by 22
Demirkıran, A., Everaars, H., Elitok, A., van de Ven, P. M., Smulders, Y. M., Dreijerink, K. M. A., Tanakol, R., & Özcan, M. (2019) · Journal of Clinical Hypertension · doi:10.1111/jch.13585 · Cited by 23
Regulation of aldosterone production by ion channels: From basal secretion to primary aldosteronism
Yang, T., He, M., & Hu, C. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.12.034 · Cited by 22
Outcomes After Surgery for Unilateral Dominant Primary Aldosteronism in Sweden
Sellgren, F., Koman, A., Nordenström, E., Hellman, P., Hennings, J., & Muth, A. (2019) · World Journal of Surgery · doi:10.1007/s00268-019-05265-8 · Cited by 22
Bilateral Idiopathic Adrenal Hyperplasia: Genetics and Beyond
Fernandes-Rosa, F. L., Boulkroun, S., Jeunemaı̂tre, X., & Zennaro, M. (2015) · Hormone and Metabolic Research · doi:10.1055/s-0035-1565198 · Cited by 21
Kishimoto, S., Oki, K., Maruhashi, T., Kajikawa, M., Matsui, S., Hashimoto, H., Takaeko, Y., Kihara, Y., Chayama, K., Goto, C., et al. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001989 · Cited by 20
Manosroi, W., Phudphong, P., Atthakomol, P., & Phimphilai, M. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-01135-y · Cited by 20
What We Know about and What Is New in Primary Aldosteronism
Ekman, N., Grossman, A. B., & Dworakowska, D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020900 · Cited by 26
Outcomes of Drug-Based and Surgical Treatments for Primary Aldosteronism
Steichen, O., Lorthioir, A., Zinzindohoué, F., Plouin, P., & Amar, L. (2015) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2014.10.003 · Cited by 20
Self-citationImpact of cone beam - CT on adrenal vein sampling in primary aldosteronism
Meyrignac, O., Arcis, É., Delchier, M.-C., Mokrane, F., Darcourt, J., Rousseau, H., & Bouhanick, B. (2019) · European Journal of Radiology · doi:10.1016/j.ejrad.2019.108792 · Cited by 20
Non-Hypertensive Effects of Aldosterone
Ekman, N., Grossman, A. B., Nieckarz, A., Jędrzejewski, Ł., Wolf, J., & Dorota Dworakowska, B. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020540 · Cited by 19
A Bibliometric Analysis of Primary Aldosteronism Research From 2000 to 2020
Wang, C., Jing, H., Sun, Z., Yao, J., Zhang, X., Liu, T., & Wu, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.665912 · Cited by 20
Kaneko, H., Umakoshi, H., Ogata, M., Wada, N., Ichijo, T., Sakamoto, S., Watanabe, T., Ishihara, Y., Tagami, T., Iwahashi, N., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-09706-8 · Cited by 18
Cardiovascular and metabolic characters of KCNJ5 somatic mutations in primary aldosteronism
Chang, Y., Lee, B., Chen, Z., Tsai, C., Chang, C., Liao, C., Pan, C., Peng, K., Chou, C., Lu, C., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1061704 · Cited by 19
Wu, V., Chen, J., Lin, Y., Wang, C., & Lai, C. (2023) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2023.09.005 · Cited by 19
The Potential of ACTH in the Genesis of Primary Aldosteronism
Funder, J. W. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00040 · Cited by 19
Kishimoto, R., Oki, K., Yoneda, M., Gómez-Sánchez, C. E., Ohno, H., Kobuke, K., Itcho, K., & Kohno, N. (2016) · Medicine · doi:10.1097/md.0000000000003659 · Cited by 19
Teo, A. E. D., Garg, S., Johnson, T. I., Zhao, W., Zhou, J., Gómez-Sánchez, C. E., Gurnell, M., & Brown, M. J. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.09156 · Cited by 19
Old and new genes in primary aldosteronism
Boulkroun, S., Fernandes-Rosa, F. L., & Zennaro, M. (2020) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2020.101375 · Cited by 20
Wu, Q., Hong, M., Xu, J., Tang, X., Zhu, L., Gao, P., & Wang, J. (2021) · Endocrine · doi:10.1007/s12020-021-02606-3 · Cited by 19
Benefits of Surgical Over Medical Treatment for Unilateral Primary Aldosteronism
Ahmed, S., & Hundemer, G. L. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.861581 · Cited by 19
Maruyama, K., Sofue, K., Okada, T., Koide, Y., Ueshima, E., Iguchi, G., Tani, R., Gentsu, T., Horinouchi, H., Sasaki, K., et al. (2018) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-018-2135-5 · Cited by 19
Nayak, S. S., Amini‐Salehi, E., Joukar, F., Biswas, P., Nobakht, S., Letafatkar, N., Porteghali, P., Mohammadi‐Vajari, E., Mansour‐Ghanaei, F., Javid, M., et al. (2024) · International Journal of Surgery · doi:10.1097/js9.0000000000002048 · Cited by 18
Sodium Infusion Test for Diagnosis of Primary Aldosteronism in Chinese Population
Li, Y., Liu, Y., Li, J., Wang, X., & Yu, Y. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2840 · Cited by 18
Diagnosing endocrine hypertension: a practical approach
Yang, J., Shen, J., & Fuller, P. J. (2017) · Nephrology · doi:10.1111/nep.13078 · Cited by 19
Wang, D., Xu, J., Chen, X., Chen, Y., Shao, S., Zhang, W., Zhu, L., Xu, T., Li, Y., & Wang, J. (2018) · American Journal of Hypertension · doi:10.1093/ajh/hpy175 · Cited by 18
Validation of the Aldosteronoma Resolution Score Within Current Clinical Practice
Vorselaars, W. M. C. M., van Beek, D., Postma, E. L., Spiering, W., Rinkes, I. H. M. B., Valk, G. D., Vriens, M. R., International CONNsortium Study Group, Zarnegar, R., Fahey, T. J., et al. (2019) · World Journal of Surgery · doi:10.1007/s00268-019-05074-z · Cited by 18
Tuersun, T., Luo, Q., Zhang, Z., Wang, G., Zhang, D., Wang, M., Wu, T., Zhou, K., Yue, N., & Li, N. (2020) · Hypertension Research · doi:10.1038/s41440-020-0529-7 · Cited by 18
Chan, C., Yang, W., Lin, Y., Huang, K., Lu, C., Hu, Y., Wu, V., Chueh, S., Chu, T., & Chen, Y. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa566 · Cited by 18
Adrenal vein sampling for primary aldosteronism: a 15-year national referral center experience
Kocjan, T., Jensterle, M., Vidmar, G., Vrckovnik, R., Berden, P., & Stankovič, M. (2020) · Radiology and Oncology · doi:10.2478/raon-2020-0052 · Cited by 19
Galati, S.-J. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.02.010 · Cited by 18
Metadata
- Authors
- Savard, S., Amar, L., Plouin, P.-F., & Steichen, O.
- Affiliations
- Assistance Publique – Hôpitaux de Paris (FR)
- Venue
- Hypertension
- Published
- 2013-08
- Volume
- 62
- Issue
- 2
- Pages
- 331-336
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2168924012
- Cited by
- 505
- References
- 50
- Citations by year
- 2026: 24 · 2025: 34 · 2024: 37 · 2023: 39 · 2022: 48 · 2021: 46 · 2020: 41 · 2019: 43 · 2018: 38 · 2017: 47 · 2016: 32 · 2015: 37 · 2014: 29 · 2013: 10
- FWCI
- 28.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Hypertension (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Health Sciences › Medicine › Nephrology › Potassium and Related Disorders
- Keywords
- primary aldosteronism, cardiovascular complications, essential hypertension, left ventricular hypertrophy, coronary artery disease, myocardial infarction, heart failure, atrial fibrillation, aldosterone-renin ratio, serum potassium, plasma aldosterone, target organ damage
- MeSH terms
- Adult, Cardiovascular Diseases, Cross-Sectional Studies, Female, Humans, Hyperaldosteronism, Hypertension, Male, Middle Aged, Hypertrophy, Left Ventricular
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review